Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086216
Status:
COMPLETED
Last Update Posted:
2007-12-21
First Post:
2004-06-28
Brief Title:
Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma
Sponsor:
Callisto Pharmaceuticals
Organization:
Callisto Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Myeloma |
Keywords:
| Name | View |
|---|---|
| Multiple myeloma | View |